News

FDA, Merck and Cancer Drug

US FDA approves AbbVie's drug for a type of lung cancer
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received previous treatment, the drugmaker said on Wednesday. The treatment, branded as Emrelis,
US FDA Expands Use of Merck's Cancer Drug for Adrenal Gland Tumors
US FDA Expands Use of Merck's Cancer Drug for Adrenal ... caused by certain genetic syndromes or mutations. The regulator's approval was based on a study in which Welireg showed an objective ...
FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for adult and pediatric patients 12 years and older with locally advanced, unresectable,
Merck wins FDA label expansion for Welireg in neuroendocrine tumors
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck’s (NYSE:MRK) anti-cancer agent Welireg (belzutifan) as a treatment for rare neuroendocrine tumors, pheochromocytoma, or paraganglioma.
AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer
AbbVie ABBV announced that the FDA has granted accelerated approval to its antibody-drug conjugate (ADC), telisotuzumab vedotin (or Teliso-V), for treating certain patients with non-small cell lung cancer (NSCLC).
AbbVie Gets FDA Nod For Drug To Treat Lung Cancer: Retail’s Yet To React
The company also announced a collaboration and license option agreement with ADARx Pharmaceuticals to develop small interfering RNA (siRNA) therapeutics across multiple disease areas, including neuroscience,
Yahoo Finance3d
FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®
This period of statutory exclusivity means that the FDA will not approve another mesenchymal stromal or stem cell (MSC) products for this indication during the 7-year period from the approval of ...
Healio9d
FDA approves, expands use of natural food dyes
The FDA announced it has approved the use of two color additives from natural sources in over a dozen foods and beverages while expanding the approval of another. According to a press release ...
Longview News-Journal19d
Historic achievement: FDA approval of Abeona Therapeutics' ZEVASKYN accelerates momentum and expands treatment options for the EB community.
This approval marks a historic moment for the EB community as the third FDA approved treatment and the first autologous, cell-based gene therapy for RDEB (Recessive Dystrophic Epidermolysis ...